Correction to Controlled Drugs (Drug Precursors) Regulations

This correction slip addresses two minor typographical errors within the draft Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026. The corrections are to regulation 6(9)(b), changing 'in the third place' to 'in the second place', and regulation 6(21)(a), changing 'for the “United Kingdom”' to 'for “the United Kingdom”'. These changes do not alter the substantive meaning or regulatory impact of the regulations.

Compliance officers and affected entities should note these corrections when referencing the regulations. No immediate action is required as these are purely editorial amendments to an existing draft. The corrected text will be incorporated into the final published version of the regulations.